Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease. (Q54387640)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Monique Roobol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

Theodorus H Van der Kwast

3 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

A Marije Hoogland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Fritz H Schröder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mark F Wildhagen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Guido Jenster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Geert J L H van Leenders

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

27 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

488-496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

Expression of basal cell keratins in human prostate cancer metastases and cell lines

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Human prostate cancer precursors and pathobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Generation of a prostate from a single adult stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Retracted: Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Stem cell characteristics in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Activation of c-MET induces a stem-like phenotype in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

CD133, a novel marker for human prostatic epithelial stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Prevalence of KIT expression in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Expression analysis of putative stem cell markers in human benign and malignant prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22768

21 January 2018

Identifiers

DOI

10.1002/PROS.22768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json

release_a747yxj4bralfeictppfini2ry

3 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a747yxj4bralfeictppfini2ry

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375374%20AND%20SRC:MED&resulttype=core&format=json